Robert H. Blankemeyer Joins Board of Directors for BioHorizons, a Leading Dental Implant Manufacturer

BIRMINGHAM, Alabama---BioHorizons, Inc., a medical device company that designs, develops, manufactures and markets a broad and comprehensive line of innovative, proprietary and evidence-based dental implants, as well as hard and soft tissue regeneration products for the replacement of missing teeth, announced today that Robert H. Blankemeyer has been elected to the BioHorizons Board of Directors.

Mr Blankemeyer is an accomplished medical device industry executive. For the last 11 years, he was employed at Medtronic, Inc. where he was Senior Vice President and President of the Surgical Technologies sector. He also served on the Medtronic executive committee, operating committee and venture board and corporate management incentive plan committee.

Prior to joining Medtronic, Mr Blankemeyer spent 22 years in the field of ophthalmology with Storz Ophthalmics having held senior positions in global sales and marketing management, as well as chief operating officer and president. Storz was a subsidiary of American Home Products and American Cyanamid, where he was a member of the President's Council.

Mortimer (Tim) Berkowitz III, Chairman of BioHorizons, said "We are delighted to welcome Bob to the Board of BioHorizons. Bob is a highly respected leader with a remarkable track record of success in the medical device industry and we look forward to adding his operating experience and strategic vision to our Board."

Steve Boggan, the Company's President and Chief Executive Officer, stated "I am excited to have the opportunity to work with Bob and receive the benefit of his deep experience in the medical device industry."